Avenue Therapeutics Stock Today
| ATXI Stock | USD 0.38 0.04 9.52% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Avenue Therapeutics is trading at 0.38 as of the 20th of March 2025. This is a 9.52 percent decrease since the beginning of the trading day. The stock's open price was 0.42. Avenue Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acuteintensive care hospital setting. The company was incorporated in 2015 and is based in New York, New York. Avenue Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 2.05 M outstanding shares of which 92.16 K shares are presently shorted by private and institutional investors with about 0.65 trading days to cover. More on Avenue Therapeutics
Moving together with Avenue Pink Sheet
Moving against Avenue Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Avenue Pink Sheet Highlights
| Executive President | Srinivas Subramanian |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Avenue Therapeutics [ATXI] is a Pink Sheet which is traded between brokers over the counter. Avenue Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 862.65 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avenue Therapeutics's market, we take the total number of its shares issued and multiply it by Avenue Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avenue Therapeutics conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 2.05 M outstanding shares of which 92.16 K shares are presently shorted by private and institutional investors with about 0.65 trading days to cover.
Avenue Therapeutics currently holds about 890 K in cash with (9.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Avenue Therapeutics Probability Of Bankruptcy
Ownership AllocationAvenue Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Avenue Ownership Details
Avenue Therapeutics Risk Profiles
| Risk Adjusted Performance | (0.20) | |||
| Jensen Alpha | (1.82) | |||
| Total Risk Alpha | (1.24) | |||
| Treynor Ratio | (1.20) |
Avenue Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Avenue Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Other Information on Investing in Avenue Pink Sheet
Avenue Therapeutics financial ratios help investors to determine whether Avenue Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avenue with respect to the benefits of owning Avenue Therapeutics security.